84 related articles for article (PubMed ID: 20880384)
1. Interaction of morphine and potassium channel openers on experimental models of pain in mice.
Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
Fundam Clin Pharmacol; 2011 Aug; 25(4):479-84. PubMed ID: 20880384
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
Welch SP; Dunlow LD
J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain.
Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
West Indian Med J; 2010 Oct; 59(5):473-8. PubMed ID: 21473392
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive action of epidural K+(ATP) channel openers via interaction with morphine and an alpha(2)- adrenergic agonist in rats.
Asano T; Dohi S; Iida H
Anesth Analg; 2000 May; 90(5):1146-51. PubMed ID: 10781469
[TBL] [Abstract][Full Text] [Related]
5. The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats.
Afify EA; Khedr MM; Omar AG; Nasser SA
Fundam Clin Pharmacol; 2013 Dec; 27(6):623-31. PubMed ID: 23033987
[TBL] [Abstract][Full Text] [Related]
6. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
7. Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice.
Khalilzadeh O; Anvari M; Khalilzadeh A; Sahebgharani M; Zarrindast MR
Int J Neurosci; 2008 Apr; 118(4):503-18. PubMed ID: 18322859
[TBL] [Abstract][Full Text] [Related]
8. Effect of ATP sensitive potassium channel modifiers on antinociceptive effect of metoclopramide.
Reddy PM; Shantanu S; Shewade DG; Ramaswamy S
Indian J Exp Biol; 2001 May; 39(5):476-8. PubMed ID: 11510133
[TBL] [Abstract][Full Text] [Related]
9. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test.
Budni J; Gadotti VM; Kaster MP; Santos AR; Rodrigues AL
Eur J Pharmacol; 2007 Dec; 575(1-3):87-93. PubMed ID: 17761162
[TBL] [Abstract][Full Text] [Related]
10. ATP-sensitive K+ channel openers inhibit morphine withdrawal.
Robles LI; Barrios M; Baeyens JM
Eur J Pharmacol; 1994 Jan; 251(1):113-5. PubMed ID: 8137867
[TBL] [Abstract][Full Text] [Related]
11. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
Luger TJ; Farkas W; Geisler H; Lorenz IH
Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
13. Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Asadi S; Sadeghipour H; Ghasemi M; Ebrahimi F; Tavakoli S; Hajrasouliha AR; Dehpour AR
Epilepsy Res; 2007 Jun; 75(1):63-9. PubMed ID: 17517498
[TBL] [Abstract][Full Text] [Related]
14. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
[TBL] [Abstract][Full Text] [Related]
15. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
Ocaña M; Barrios M; Baeyens JM
J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
[TBL] [Abstract][Full Text] [Related]
16. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
17. Role of Na(+), K(+)-ATPase in morphine-induced antinociception.
Masocha W; Horvath G; Agil A; Ocana M; Del Pozo E; Szikszay M; Baeyens JM
J Pharmacol Exp Ther; 2003 Sep; 306(3):1122-8. PubMed ID: 12756273
[TBL] [Abstract][Full Text] [Related]
18. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
19. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
